Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-25-324826

Chief Executive Officer sold 10,916 shares at an average $29.64 ($323,508)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ceesay Abraham Chief Executive Officer 2025-12-17 Sale 10b5-1 −2,441 $28.84 $70,393 571,305 D
Ceesay Abraham Chief Executive Officer 2025-12-17 Sale 10b5-1 −2,792 $30.04 $83,862 568,513 D
Ceesay Abraham Chief Executive Officer 2025-12-17 Sale 10b5-1 −600 $31.04 $18,622 567,913 D
Ceesay Abraham Chief Executive Officer 2025-12-17 Sale 10b5-1 −2,147 $28.84 $61,925 33,831 I
Ceesay Abraham Chief Executive Officer 2025-12-17 Sale 10b5-1 −2,421 $30.04 $72,722 31,410 I
Ceesay Abraham Chief Executive Officer 2025-12-17 Sale 10b5-1 −515 $31.04 $15,985 30,895 I
Open-market sales · 10,916 sh · avg $29.64 · $323,508
Loading xslF345X05/ownership.xml…